Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
InorbitTX visit to Swiss Nordic Bio 2022
| Reference number | 2021-04960 |
| Coordinator | Inorbit Therapeutics AB |
| Funding from Vinnova | SEK 10 000 |
| Project duration | December 2021 - January 2022 |
| Status | Completed |
InOrbitTX was presented and potential investors and alliance partners were met.
We hope that one or more of the new contacts will invest in InOrbitTX.
???
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
Last updated 10 December 2021
Reference number 2021-04960
